SOCS2 regulates alveolar bone loss in Aggregatibacter actinomycetemcomitans-induced periodontal disease

[1]  J. Cruz,et al.  SOCS2 expression in hematopoietic and non-hematopoietic cells during Trypanosoma cruzi infection: Correlation with immune response and cardiac dysfunction. , 2021, Clinical immunology.

[2]  R. Jia,et al.  SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses , 2020, Frontiers in Immunology.

[3]  Yinan Jia,et al.  Role of Hippo-YAP Signaling in Osseointegration by Regulating Osteogenesis, Angiogenesis, and Osteoimmunology , 2020, Frontiers in Cell and Developmental Biology.

[4]  T. Kaito,et al.  Osteoclast Multinucleation: Review of Current Literature , 2020, International journal of molecular sciences.

[5]  C. Queiroz-Junior,et al.  SUPPRESSORS OF CYTOKINE SIGNALING (SOCS) PROTEINS IN INFLAMMATORY BONE DISORDERS. , 2020, Bone.

[6]  J. Jansen,et al.  The effect of lipoxin A4 on E. coli LPS-induced osteoclastogenesis , 2020, Clinical Oral Investigations.

[7]  Yan Liu,et al.  Mechanical load-induced H2S production by periodontal ligament stem cells activates M1 macrophages to promote bone remodeling and tooth movement via STAT1 , 2020, Stem Cell Research & Therapy.

[8]  G. Hajishengallis.  New developments in neutrophil biology and periodontitis. , 2020, Periodontology 2000.

[9]  M. Teixeira,et al.  Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis , 2019, Mediators of inflammation.

[10]  M. Teixeira,et al.  SOCS2 modulates adipose tissue inflammation and expansion in mice. , 2019, The Journal of nutritional biochemistry.

[11]  G. Garlet,et al.  Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms , 2019, Front. Immunol..

[12]  T. Nicholson,et al.  Mnesic imbalance: a cognitive theory about autism spectrum disorders , 2008, Annals of General Psychiatry.

[13]  N. Rucci,et al.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System , 2019, Front. Endocrinol..

[14]  B. A. David,et al.  SOCS2 Is Critical for the Balancing of Immune Response and Oxidate Stress Protecting Against Acetaminophen-Induced Acute Liver Injury , 2019, Front. Immunol..

[15]  R. Vernal,et al.  Alveolar bone resorption and Th1/Th17‐associated immune response triggered during Aggregatibacter actinomycetemcomitans‐induced experimental periodontitis are serotype‐dependent , 2018, Journal of periodontology.

[16]  Ji-Hong Liu,et al.  Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis , 2017, Asian journal of andrology.

[17]  N. Ishimaru,et al.  The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis , 2016, The Journal of Immunology.

[18]  H. Tanowitz,et al.  Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria , 2016, Brain, Behavior, and Immunity.

[19]  M. Walsh,et al.  Tumor necrosis factor receptor‐ associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system , 2015, Immunological reviews.

[20]  A. Johansson,et al.  Aggregatibacter actinomycetemcomitans: Virulence of its leukotoxin and association with aggressive periodontitis , 2014, Virulence.

[21]  A. Yoshimura,et al.  SOCS, inflammation, and metabolism , 2014 .

[22]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor catabolic activity in bone metabolism is osteoclast dependent in vivo. , 2014, Biochemical and biophysical research communications.

[23]  A. Johansson,et al.  Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis , 2014, Journal of oral microbiology.

[24]  G. Garlet,et al.  Platelet-Activating Factor Receptor Blockade Ameliorates Aggregatibacter actinomycetemcomitans-Induced Periodontal Disease in Mice , 2013, Infection and Immunity.

[25]  G. Garlet,et al.  SOCS3 Expression Correlates with Severity of Inflammation, Expression of Proinflammatory Cytokines, and Activation of STAT3 and p38 MAPK in LPS-Induced Inflammation In Vivo , 2013, Mediators of inflammation.

[26]  M. Lisanti,et al.  Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. , 2012, The American journal of pathology.

[27]  P. Arirachakaran,et al.  Infection of human gingival fibroblasts with Aggregatibacter actinomycetemcomitans: An in vitro study. , 2012, Archives of oral biology.

[28]  J. Aliberti,et al.  SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses , 2012, PloS one.

[29]  G. Norstedt,et al.  SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high‐fat‐diet‐fed mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  G. Garlet,et al.  MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice. , 2012, Microbes and infection.

[31]  J. A. C. de Souza,et al.  Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. , 2011, Archives of oral biology.

[32]  G. Garlet,et al.  Experimental Arthritis Triggers Periodontal Disease in Mice: Involvement of TNF-α and the Oral Microbiota , 2011, The Journal of Immunology.

[33]  Gernot Posselt,et al.  Suppressor of Cytokine Signaling 2 Is a Feedback Inhibitor of TLR-Induced Activation in Human Monocyte-Derived Dendritic Cells , 2011, The Journal of Immunology.

[34]  P. Tessier,et al.  Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption. , 2009, Blood.

[35]  E. Wagner,et al.  NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1* , 2007, Journal of Biological Chemistry.

[36]  G. Garlet,et al.  Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression? , 2006, Journal of periodontal research.

[37]  C. Adams,et al.  Active caspase‐3 is required for osteoclast differentiation , 2006, Journal of cellular physiology.

[38]  J. Tavernier,et al.  Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling* , 2006, Journal of Biological Chemistry.

[39]  J. Johndrow,et al.  Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.

[40]  S. Akira,et al.  Suppressor of cytokine signaling-1 selectively inhibits LPS-induced IL-6 production by regulating JAK-STAT. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Johnston,et al.  SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation , 2005, Molecular and Cellular Biology.

[42]  K. Rakesh,et al.  Controlling cytokine signaling by constitutive inhibitors. , 2005, Biochemical pharmacology.

[43]  S. Mohan,et al.  Reduced Bone Mineral Density in SOCS-2-Deficient Mice , 2005, Pediatric Research.

[44]  S. Haque,et al.  The Possible Role of TGF-β-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro1 , 2003, The Journal of Immunology.

[45]  M. Kubo,et al.  SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. , 2002, Immunity.

[46]  M. Kumegawa,et al.  Regulation of Receptor Activator of NF-κB Ligand-induced Osteoclastogenesis by Endogenous Interferon-β (INF-β) and Suppressors of Cytokine Signaling (SOCS) , 2002, The Journal of Biological Chemistry.

[47]  P. Kelly,et al.  Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. , 2001, Endocrinology.

[48]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[49]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[50]  T. V. Van Dyke,et al.  Host modulation: controlling the inflammation to control the infection , 2017, Periodontology 2000.

[51]  S. Haan,et al.  SOCS2: physiological and pathological functions. , 2016, Frontiers in bioscience.